GlassScriptPhysician profile
Vinay Mehta
NPI 1346455755
$4,156.95
in general payments reported to CMS, 2019-2025
16 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.51 · 2021: $28.83 · 2022: $2,935 · 2023: $452 · 2024: $415 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,122.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $2,694.09 | 2022 | |
| Regeneron Pharmaceuticals, INC. | $379.40 | 2023-2024 | Dupixent |
| Biosense Webster, INC. | $277.71 | 2023-2025 | Carto 3 |
| Medtronic, INC. | $239.43 | 2022-2025 | Azure Xt Dr Mri Surescan, Amplia Mri Quad Crt-D Surescan, Symplicity G3 |
| Cardiva Medical, INC. | $166.85 | 2023-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Regeneron Healthcare Solutions, INC. | $147.13 | 2022-2024 | Dupixent |
| Janssen Pharmaceuticals, INC | $59.50 | 2019 | |
| Pharming Healthcare, INC. | $40.41 | 2023 | Ruconest |
| Takeda Pharmaceuticals U.S.A., INC. | $31.24 | 2022 | |
| Horizon Therapeutics Plc | $29.24 | 2022 | |
| Boston Scientific Corporation | $28.83 | 2021 | |
| Optinose US, INC. | $22.17 | 2022 | |
| Alnylam Pharmaceuticals INC. | $16.71 | 2023 | Onpattro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.23 | 2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $12.01 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinay Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.